Follow
Ciprian Tomuleasa
Ciprian Tomuleasa
Verified email at umfcluj.ro
Title
Cited by
Cited by
Year
Exosomes as divine messengers: are they the Hermes of modern molecular oncology?
C Braicu, C Tomuleasa, P Monroig, A Cucuianu, I Berindan-Neagoe, ...
Cell Death & Differentiation 22 (1), 34-45, 2015
2692015
Human bile contains microRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis
L Li, D Masica, M Ishida, C Tomuleasa, S Umegaki, AN Kalloo, ...
Hepatology 60 (3), 896-907, 2014
1932014
The new era of nanotechnology, an alternative to change cancer treatment
A Jurj, C Braicu, LA Pop, C Tomuleasa, CD Gherman, I Berindan-Neagoe
Drug design, development and therapy 11, 2871, 2017
1372017
Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
C Tomuleasa, O Soritau, D Rus-Ciuca, T Pop, D Todea, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 19 (1), 2010
1262010
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
C Tomuleasa, O Soritau, A Orza, M Dudea, B Petrushev, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 21 (2), 2012
1142012
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer
F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ...
J Gastrointestin Liver Dis 24 (4), 435-443, 2015
892015
MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer
S Yamanaka, AV Olaru, F An, D Luvsanjav, Z Jin, R Agarwal, ...
Digestive and Liver Disease 44 (7), 589-596, 2012
852012
A comprehensive picture of extracellular vesicles and their contents. Molecular transfer to cancer cells
A Jurj, O Zanoaga, C Braicu, V Lazar, C Tomuleasa, A Irimie, ...
Cancers 12 (2), 298, 2020
792020
MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog
L Li, L Zhou, Y Li, S Lin, C Tomuleasa
J buon 19 (1), 228-236, 2014
732014
Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched …
S Gaballa, I Ge, R El Fakih, JE Brammer, P Kongtim, C Tomuleasa, ...
Cancer 122 (21), 3316-3326, 2016
692016
Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma
H Peng, M Ishida, L Li, A Saito, A Kamiya, JP Hamilton, R Fu, AV Olaru, ...
Oncotarget 6 (8), 5666, 2015
662015
How to diagnose and treat a cancer of unknown primary site.
C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ...
Journal of Gastrointestinal & Liver Diseases 26 (1), 2017
602017
Nanopharmacology in translational hematology and oncology
C Tomuleasa, C Braicu, A Irimie, L Craciun, I Berindan-Neagoe
International Journal of Nanomedicine 9, 3465, 2014
572014
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
A Orza, O Soriţău, C Tomuleasa, L Olenic, A Florea, O Pana, I Bratu, ...
International journal of nanomedicine 8, 689, 2013
552013
Nanomedicine approaches in acute lymphoblastic leukemia
AS Tatar, T Nagy-Simon, C Tomuleasa, S Boca, S Astilean
Journal of Controlled Release 238, 123-138, 2016
542016
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
M Aldea, L Craciun, C Tomuleasa, I Berindan-Neagoe, G Kacso, ...
Tumor Biology 35 (6), 5101-5110, 2014
542014
Antiproliferative effect of novel platinum (II) and palladium (II) complexes on hepatic tumor stem cells in vitro
N Miklášová, E Fischer-Fodor, P Lönnecke, CI Tomuleasa, P Virag, ...
European journal of medicinal chemistry 49, 41-47, 2012
522012
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations
MY Shah, M Ferracin, V Pileczki, B Chen, R Redis, L Fabris, X Zhang, ...
Genome research 28 (4), 432-447, 2018
512018
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells
MD Aldea, B Petrushev, O Soritau, CI Tomuleasa, I Berindan-Neagoe, ...
J buon 19 (2), 502-511, 2014
512014
Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
M Carmignani, AR Volpe, M Aldea, O Soritau, A Irimie, IS Florian, ...
Journal of biological regulators and homeostatic agents 28 (1), 1-15, 2014
512014
The system can't perform the operation now. Try again later.
Articles 1–20